Diabetic and Metabolic research solutions
Inotiv
CLOSE ×

Harnessing the Power of PDX and CDX Models for Personalized Medicine Approaches

Welcome to Inotiv’s cutting-edge oncology research solutions, where innovation meets precision in the pursuit of efficient drug discovery and development. At Inotiv, we are dedicated to pioneering advancements in oncology research, providing cutting-edge solutions for pharmaceutical and biotechnology companies seeking to innovate in cancer treatment.

Inotiv specializes in patient-derived xenografts (PDX) and cell-derived xenografts (CDX) tumor studies, established and powerful tools in the fight against cancer. PDX models offer a remarkable representation of human tumors, maintaining the complex tumor microenvironment for more accurate preclinical testing. Our expertise in oncology models allows for personalized medicine approaches, tailoring treatments to the individual patient.

Partner with Inotiv and harness the power of innovative technologies, experienced scientists, and a commitment to advancing cancer therapeutics. Together, we can drive discoveries that make a difference in the lives of patients worldwide. Contact us today to learn more about our oncology research services.

What to Expect From Your Oncology Team

Define the Research Question and Area of Focus

Literature Review and Background Research

Choose a Research Model

Conduct the Experiment and Data Analysis

Disseminate the Results

hd-male-pen-microscope

Maximizing oncology research success Podcast

Listen to Podcast Listen to Podcast  
Group of business people working over digital tablet and laptop in the office

Speak to an Expert

Contact Our Oncology Specialist

Contact A Specialist Contact A Specialist  

 

 

Subscribe to updates from Inotiv

Sign up and you’ll receive the latest updates that matter to you, delivered straight to your inbox.

Subscribe now